Phosphagenics Limited
ASX:POH ISIN:AU000000POH7
Phosphagenics' core technology is built around the science and application of phosphorylation, a process where the addition of a phosphate group has been found to enhance the bioavailability, activity and safety of existing pharmaceuticals and nutraceuticals, as well as to assist in the production of drug delivery platforms.
Phosphagenics' shares are listed on the Australian Stock Exchange (POH) and the London Stock Exchange's Alternative Investment Market (PSG). An ADR - Level 1 program was established in the U.S. with The Bank of New York Mellon (PPGNY) for U.S. investors to trade in Phosphagenics' stock on the 'over-the-counter' market. In July 2007, this was upgraded to the International OTCQX, a new premium market tier in the U.S. for international exchange-listed companies, operated by Pink Sheets, LLC.
Nouvelles
Le rapport du marché australien du 7 février 2011 inclut les titres suivants: Automotive Technology Group Limited (ASX:ATJ) annonce que le compresseur d'alimentation Sprintex(R) de la compagnie est le système de compresseur le plus efficace au monde; une étude sur le charbon met en lumière un potentiel d'exploitation de charbon thermique de catégorie d'exportation pour le projet Mmamantswe d'Aviva Corporation Limited (ASX:AVA) au Botswana; EnviroGold Limited (ASX:EVG) a renforcé son équipe de direction de manière significative en Amérique du Sud; Phosphagenics Limited (ASX:POH) a annoncé une collaboration pour développer un nouveau médicament contre le psoriasis aux Etats-Unis.
88,732 COMPANY PROFILE VIEWS
- This Page Viewed: (7 derniers jours: 11) (Last 30 Days: 54) (Since Published: 6993)